Free tool
Drugs in development
Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations
Drugs in development
3,685
Not FDA-approved
In Phase 3
1,424
Highest phase reached
Matching your filters
1,268
1,268 drugs in development
Names, sponsors and conditions come from the trial records. Click a drug for its trials.
- IMP4927Phase 31 trial
Impact Therapeutics, Inc. · Ovarian Cancer
- INBRX-106OrdastobartPhase 31 trial
Inhibrx Biosciences, Inc · Head and Neck Squamous Cell Carcinoma (HNSCC), HPV Oropharyngeal Squamous Cell Carcinoma (HPV+ OPSCC)
- INCB161734Phase 31 trial
Incyte · Solid Tumors
- include docetaxelPhase 31 trial
Shanghai Runshi Pharmaceutical Technology Co., Ltd · Advanced Oesophageal Squamous Cell Carcinoma
- INT230-6Phase 31 trial
Intensity Therapeutics, Inc. · Sarcoma,Soft Tissue
- ipilimumab and nivolumabPhase 31 trial
Linnaeus Therapeutics, Inc. · Melanoma (Skin Cancer), Melanoma Stage IIIB-IV, Cutaneous Melanoma
- IptilimumabPhase 31 trial
InSightec · Brain Tumor, Non Small Cell Lung Cancer
- JMKX001899Phase 31 trial
Jemincare · NSCLC (Non-small Cell Lung Cancer)
- JNJ-87189401Phase 31 trial
Johnson & Johnson (Janssen) · Metastatic Castration-resistant Prostatic Neoplasms
- JYP0035Phase 31 trial
Chengdu JOYO pharma Co., Ltd. · Breast Cancer
- LerotinibZ650Phase 31 trial
Sunshine Lake Pharma Co., Ltd. · Esophageal Cancer
- LNS8801Phase 31 trial
Linnaeus Therapeutics, Inc. · Melanoma (Skin Cancer), Melanoma Stage IIIB-IV, Cutaneous Melanoma
- LY01015Phase 31 trial
Shandong Boan Biotechnology Co., Ltd · Esophageal Squamous Cell Carcinoma
- MB11Proposed Nivolumab BiosimilarPhase 31 trial
mAbxience Research S.L. · Advanced (Unresectable or Metastatic) Melanoma
- MB12Proposed Pembrolizumab BiosimilarPhase 31 trial
mAbxience Research S.L. · Non Squamous Non Small Cell Lung Cancer
- MRG002Phase 31 trial
Shanghai Miracogen Inc. · Advanced or Metastatic Urothelium Cancer
- MRG004APhase 31 trial
Lepu Biopharma Co., Ltd. · Advanced Pancreatic Cancer
- NB003Phase 31 trial
Ningbo Newbay Technology Development Co., Ltd · GIST - Gastrointestinal Stromal Tumor, Advanced
- New of NiraparibPhase 31 trial
Johnson & Johnson (Janssen) · Castration-Resistant Prostatic Cancer
- nivolumab and relatlimabPhase 31 trial
Linnaeus Therapeutics, Inc. · Melanoma (Skin Cancer), Melanoma Stage IIIB-IV, Cutaneous Melanoma
- NofazinlimabPhase 31 trial
CStone Pharmaceuticals · Hepatocellular Carcinoma
- NP-101Phase 31 trial
Novatek Pharmaceuticals · Gastroenteropancreatic Neuroendocrine Tumors
- NRT6003Yttrium-90 carbon microspheresPhase 31 trial
Chengdu New Radiomedicine Technology Co. LTD. · Unresectable Hepatocellular Carcinoma
- NTQ1062Phase 31 trial
Nanjing Chia-tai Tianqing Pharmaceutical · HR Positive/HER2 Negative Advanced or Metastatic Breast Cancer
- Olaparib phasePhase 31 trial
AstraZeneca · Advanced or Recurrent Endometrial Cancer
- PaxlitaxelPhase 31 trial
Akeso · Advanced Squamous Non Small Cell Lung Cancer
- PF04518600Phase 31 trial
Pfizer · Advanced Malignancies, NSCLC, Ovarian Cancer
- PlinabulinPhase 31 trial
BeyondSpring Pharmaceuticals Inc. · Non-Small Cell Lung Cancer, Non-squamous Non-Small Cell Lung Cance
- ponsegromabPhase 31 trial
Pfizer · Cachexia, Metastatic Pancreatic Ductal Adenocarcinoma
- prolgolimabBCD-100, FortecaPhase 31 trial
Biocad · Melanoma, Melanoma (Skin), Melanoma Stage III
- PRV111Cisplatin Transmucosal SystemPhase 31 trial
Privo Technologies · Oral Squamous Cell Carcinoma
- PRV131Cisplatin IntratumoralPhase 31 trial
Privo Technologies · Oral Squamous Cell Carcinoma
- PRV211Intraoperative Cisplatin SystemPhase 31 trial
Privo Technologies · Oral Squamous Cell Carcinoma
- QL1604Phase 31 trial
Qilu Pharmaceutical Co., Ltd. · Small-cell Lung Cancer
- QLG1080Phase 31 trial
Qilu Pharmaceutical Co., Ltd. · Prostate Cancer
- RilogrotugPhase 31 trial
AVEO Pharmaceuticals, Inc. · Cachexia; Cancer, Cachexia, Cachexia-Anorexia Syndrome
- RinzimetostatORIC-944Phase 31 trial
ORIC Pharmaceuticals · Metastatic Castration Resistant Prostate Cancer
- RPH-051Phase 31 trial
R-Pharm · Locally Advanced Breast Cancer, Metastatic Breast Cancer
- RulonilimabPhase 31 trial
Shandong New Time Pharmaceutical Co., LTD · Cervical Cancer
- SasanlimabPF-06801591Phase 31 trial
Pfizer · Non-muscle Invasive Bladder Cancer
- SB27Phase 31 trial
Samsung Bioepis Co., Ltd. · Non-small Cell Lung Cancer Stage IV
- SBP-101ivospeminPhase 31 trial
Panbela Therapeutics, Inc. · Pancreatic Cancer Metastatic, Pancreatic Ductal Adenocarcinoma, Pancreatic Cancer Stage IV
- SGM-101Phase 31 trial
Surgimab · Colorectal Neoplasms
- SH-1028Phase 31 trial
Nanjing Sanhome Pharmaceutical, Co., Ltd. · Non-small Cell Lung Cancer
- SH006Phase 31 trial
Nanjing Sanhome Pharmaceutical, Co., Ltd. · Hepatocellular Carcinoma (HCC)
- SHR6390Phase 31 trial
Jiangsu HengRui Medicine Co., Ltd. · Hormone Receptor Positive,Human Epidermal Receptor 2 Negative, Node-positive, High Risk, Early Stage,Female Breast Cancer
- SIM0270Phase 31 trial
Jiangsu Simcere Pharmaceutical Co., Ltd. · Locally Advanced or Metastatic Breast Cancer
- SocazolimabPhase 31 trial
Lee's Pharmaceutical Limited · Cervical Cancer
- SRG-514Phase 31 trial
SURGE Therapeutics · TNBC - Triple-Negative Breast Cancer
- SurufatinibPhase 31 trial
Hutchmed · Metastatic Pancreatic Cancer
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.